Flare Syndrome and ICANS as Life-Threatening Complications of Talquetamab in Refractory Multiple Myeloma

2026 Preprint

View at publisher
Authors: Juraj Sokol, Ivana Plameňová, Lenka Lisá, Ivan Kecskés, Richard Jusko, Marianna Nehajova, Kamil Zelenak
DOI: 10.22541/au.176891777.74832404/v1
Cited by: 0

Abstract

IntroductionMultiple myeloma (MM) is a clonal malignancy of plasma cells that remains incurable despite significant therapeutic progress, and patients who relapse or become refractory after treatment with proteasome inhibitors (PIs), immunomodulatory

Fields of Study & Subjects

Multiple Myeloma Research and Treatments Pharmacovigilance and Adverse Drug Reactions Drug-Induced Adverse Reactions

Publication details

Publication date
20 January 2026
Document type
Preprint